Hundreds of patients who turn up to A&E departments in Birmingham may be turned away in a bid to protect key services, health bosses have said.
NICE and the Scottish Intercollegiate Guidelines Network (SIGN) have announced they will work with the Royal College of General Practitioners (RCGP) to develop a guideline on persistent effects of COVID-19 (Long Covid) on patients.
People suffering ‘long COVID’ symptoms will be offered specialist help at clinics across England, the head of the NHS has announced.
The UK Government has entered into a contract with Abingdon Health, on behalf of the UK-Rapid Test Consortium (“UK-RTC”), for the supply of the AbC-19 Rapid Antibody tests.
Interim results from the fourth report of the country’s largest study on coronavirus rates of infection have been published.
A committee of MPs has highlighted the impact and unprecedented challenge caused by COVID-19 to the provision of essential services.
More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific genetic mutation.
Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 who are risk assessed prior to receiving the drug.
Research presented at the ESCMID Conference on Coronavirus Disease has investigated the accuracy of a number of antibody assays.
A 90-minute COVID-19 test has been shown to have over 94 per cent sensitivity, and 100 per cent specificity in a new study.
Speaking at the All-Party Parliamentary Group (APPG) on Coronavirus, RCN director of nursing, policy and public affairs, Susan Masters, called for an inquiry to investigate how the UK prepared for and responded to the pandemic.
A £500 million funding package is being invested in next generation testing technology and increased testing capacity, the Health and Social Care Secretary has announced.
Up to 200 staff working for Queen Victoria Hospital are being recruited to take part in a major national study to help scientists to find out more about COVID-19 antibodies and whether having COVID-19 antibodies makes someone immune to the virus.
A Medical Technology Group survey shows that patients are embracing technology during the COVID-19 pandemic, but still value real-life consultations.
The University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified that a glycoprotein known as transferrin may critically contribute to severe forms of COVID-19.